CENTRAL NERVOUS SYSTEM INJURY

CENTRAL NERVOUS SYSTEM INJURY was reported 65 times

CENTRAL NERVOUS SYSTEM INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 1 0.0009
1 Penem Antibacterial [EPC] 8 0.0002
2 Gadolinium-based Contrast Agent [EPC] 1 0.0002
3 Glycopeptide Antibacterial [EPC] 8 0.0001
4 Cardiac Glycoside [EPC] 8 0.0001
5 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
6 Insulin [EPC] 2 0.0000
7 Opioid Agonist [EPC] 10 0.0000
8 Central Nervous System Stimulant [EPC] 3 0.0000
9 Provitamin D2 Compound [EPC] 1 0.0000
10 Muscle Relaxant [EPC] 1 0.0000
11 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
12 Mood Stabilizer [EPC] 4 0.0000
13 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
14 Atypical Antipsychotic [EPC] 7 0.0000
15 Anti-epileptic Agent [EPC] 3 0.0000
16 Integrin Receptor Antagonist [EPC] 1 0.0000
17 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
18 Acetylcholine Release Inhibitor [EPC] 1 0.0000
19 Alkylating Drug [EPC] 2 0.0000
20 Fluoroquinolone Antibacterial [EPC] 1 0.0000
21 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
22 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
23 Factor Xa Inhibitor [EPC] 2 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
25 Osmotic Laxative [EPC] 2 0.0000
26 Loop Diuretic [EPC] 3 0.0000
27 Aldosterone Antagonist [EPC] 1 0.0000
28 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
29 Interferon beta [EPC] 1 0.0000
30 Corticosteroid [EPC] 6 0.0000
31 Insulin Analog [EPC] 2 0.0000
32 Platinum-based Drug [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Benzodiazepine [EPC] 2 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
36 Kinase Inhibitor [EPC] 1 0.0000